The gloves are off

Carl Icahn finally made it crystal clear that his goal in his battle with Genzyme Corp. is to depose Chairman, President and CEO Henri Termeer.

A few days in advance of the company's analyst and investor day last week, Icahn submitted a proxy statement to the SEC specifying the four directors he hopes to replace: Termeer; compensation committee chair and Massachusetts Institute of Technology (MIT) professor Charles Cooney; nominating/governance committee chair and former U.S. Sen. Connie Mack; and Richard Syron, former chairman and CEO of Freddie Mac...